Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions

Clinical Cancer Research

Volumn 15, Issue 19, 2009, Pages 6028-6034

  Takahashi Shiga, Naomi ^a   Utsunomiya, Hiroki ^a   Miki, Yasuhiro ^a   Nagase, Satoru ^a   Kobayashi, Rika ^a   Matsumoto, Mitsuyo ^a   Niikura, Hitoshi ^a   Ito, Kiyoshi ^a   Yaegashi, Nobuo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROGEN; AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTRONE; EXEMESTANE; MESSENGER RNA; TESTOSTERONE 17BETA DEHYDROGENASE;

ANIMAL CELL; AROMATIZATION; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TANDEM MASS SPECTROMETRY;

17-HYDROXYSTEROID DEHYDROGENASES; 3T3-L1 CELLS; ANIMALS; AROMATASE; CARCINOMA; CELL COMMUNICATION; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; ESTRADIOL DEHYDROGENASES; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; STROMAL CELLS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 70349687397     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1013     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Berstein LM, Tchernobrovkina AE, Gamajunova VB, et al. Tumor estrogen content and clinicomorphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol 2003; 129:245-249 (Pubitemid 36713801)
3. Ito K, Utsunomiya H, Suzuki T, et al. 17β-Hydroxysteroid dehydrogenases in human endometrium and its disorders. Mol Cell Endocrinol 2006; 248:136-140
4. Miller WR, Hawkins RA, Forrest AP. Significance ofaromata se activity in human breast cancer. Cancer Res 1982;42:3365-8s.
5. Watanabe K, Sasano H, Harada N, et al. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol 1995;146:491-500.
6. Puranen T, Poutanen M, Ghosh D, Vihko P, Vihko R. Characterization ofstructural and functional properties ofhu man 17β-hydroxysteroid dehydrogenase type 1 using recombinant enzymes and site-directed mutagenesis. Mol Endocrinol 1997;11:77-86. (Pubitemid 27021256)
7. Wu L, Einstein M, Geissler WM, et al. Expression cloning and characterization ofh uman 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 1993; 268:12964-12969 (Pubitemid 23182471)
8. Husen B, Psonka N, Jacob-Meisel M, Keil C, Rune GM. Differential expression of 17β-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines. J Mol Endocrinol 2000;24:135-144 (Pubitemid 30117667)
9. Utsunomiya H, Suzuki T, Kaneko C, et al. The analyses of17 β-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma. J Clin Endocrinol Metab 2001; 86:3436-3443 (Pubitemid 32673518)
10. Suzuki T, Moriya T, Ariga N, et al. 17β-Hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters. Br J Cancer 2000; 82:518-523 (Pubitemid 30085183)
11. Bulun SE, Chen D, Lu M, et al. Aromatase excess in cancers ofbreast, endometrium and ovary. J Steroid Biochem Mol Biol 2007;106: 81-96. (Pubitemid 47362640)
12. Miki Y, Suzuki T, Tazawa C, et al. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Cancer Res 2007;67: 3945-3954 (Pubitemid 46762184)
13. Matsumoto M, Yamaguchi Y, Seino Y, et al. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction. Endocr Relat Cancer 2008;15:451-463 (Pubitemid 351880834)
14. Suzuki T, Miki Y, Moriya T, et al. Estrogenrelated receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res 2004;64: 4670-4676 (Pubitemid 38856942)
15. Numazawa M, Yoshimura A, Oshibe M. Enzymic aromatization of6-al kyl-substituted androgens, potent competitive and mechanism- based inhibitors ofaromatase. Biochem J 1998;329:151-156 (Pubitemid 28022303)
16. Suzuki T, Miki Y, Moriya T, et al. 5α-Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer 2007;120:285-291 (Pubitemid 44956837)
17. Thomas DB. Do hormones cause breast cancer? Cancer 1984;53:595-604.
18. Hecht JL, Mutter GL. Molecular and pathologic aspects ofendometrial carcinogenesis. J Clin Oncol 2006;24:4783-4791
19. Schenker JG, Weinstein D, Okon E. Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer. Cancer 1979;44:1809-1812 (Pubitemid 10140412)
20. Judd HL, Davidson BJ, Frumar AM, et al. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 1980;136:859-871 (Pubitemid 10112650)
21. Tseng L, Mazella J, Mann WJ, Chumas J. Estrogen synthesis in normal and malignant human endometrium. J Clin Endocrinol Metab 1982;55:1029-1031
22. Yamaki J, Yamamoto T, Okada H. Aromatization ofandrostenedione by normal and neoplastic endometrium ofthe uterus. J Steroid Biochem 1985;22:63-66 (Pubitemid 15130259)
23. Pirone DM, Chen CS. Strategies for engineering the adhesive microenvironment. J Mammary Gland Biol Neoplasia 2004;9:405-417
24. Zhou J, Suzuki T, Kovacic A, et al. Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer. Cancer Res 2005;65:657-663
25. Singh A, Purohit A, Wang DY, et al. IL-6sR: release from MCF-7 breast cancer cells and role in regulating peripheral oestrogen synthesis. J Endocrinol 1995;147:R9-12.
26. 2 via cyclic AMP, leading to activation ofpro moter II of the CYP19 (aromatase) gene. Endocrinology 1996; 137:5739-5742
27. Ito K, Utsunomiya H, Yaegashi N, Sasano H. Biological roles ofestr ogen and progesterone in human endometrial carcinoma - new developments in potential endocrine therapy for endometrial cancer. Endocr J 2007;54:667-679
28. Sasano H, Frost AR, Saitoh R, et al. Aromatase and 17β- hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 1996;81:4042-4046 (Pubitemid 26380415)
29. Ma BB, Oza A, Eisenhauer E, et al. The activity oflet rozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study oft he National Cancer Institute ofCanada Clinical Trials Group. Int J Gynecol Cancer 2004;14:650-658 (Pubitemid 39062922)
30. Rose PG, Brunetto VL, VanLe L, et al. A phase II trial ofana strozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2000; 78:212-216 (Pubitemid 30650356)